McMaster Zika Study Adds to Evidence of Sex-Specific Immunity

McMaster University

That men tend to suffer more than women when they get sick is an age-old cliché. But a growing body of research suggests that there may be some truth to it.

In a new study out of McMaster University, researchers found that biological sex played a significant role in determining the severity of disease following Zika virus infection.

The findings, published in the Journal of Infectious Diseases , build on recent studies that have shown males are more likely to experience severe outcomes from viral infections, including COVID-19, influenza, and West Nile.

Ali Ashkar , a professor of Medicine at McMaster and principal investigator on the new study, suggests that the vastly different outcomes have less to do with the viruses or infections themselves and more to do with how we respond to them.

"It's becoming more and more accepted in the field that the outcomes of acute viral infections typically differ between males and females," he says. "The male immune system seems to respond more strongly to these infections, and as a consequence, the damage or inflammation to the site of infection is often more severe."

Ashkar's group, led by PhD student Alexa Mansour, investigated biological sex as a determinant of severe Zika disease by monitoring infected male and female mice. In doing so, they found that male mice were significantly more susceptible to severe neurological complications, including weakness and paralysis, than their female counterparts were.

The researchers say one of the most striking findings was that the difference in disease severity couldn't be explained away by the amount of virus replicating in the animals' bodies. Ashkar, a member of the Michael G. DeGroote Institute for Infectious Disease Research , says his team initially suspected the male subjects must have had higher levels of the virus — that perhaps the female immune system was clearing the virus quicker, before severe disease could manifest; however, further testing revealed that the male and female mice had comparable levels of Zika in both their blood and brains.

"Both the males and females were infected under the same conditions — they were nearly genetically identical, they were the exact same age, and they were infected with the same virus taken from the same vial at equal amounts," Ashkar says. "It made no sense for there to be such a huge difference in how the disease presented."

Mansour, who first-authored the new paper, says the findings were almost completely by chance. She says the lab had been studying Zika in mice over an extended period of time, when suddenly the virus's trademark neurological symptoms stopped presenting. Quickly, they realized that all of the mice in the test cohort were female. When they re-introduced male mice to the study, the severe neurological complications returned.

"We weren't initially convinced that biological sex was behind the lack of symptoms," Mansour says. "We asked ourselves, 'are we doing something wrong?' 'Are the mice somehow not getting infected?' But when we began infecting male mice again and the symptoms returned, it became clear what was happening."

Mansour says the findings, coupled with the growing body of related scientific literature, suggest that "it's really important to consider biological sex in the context of infectious disease going forward."

For Ashkar, that consideration is something that should extend beyond just research and factor into clinical care.

"From now on, for any acute viral infection, it's important for physicians to control inflammation early in male patients," Ashkar says. "We already have a lot of approved and effective anti-inflammatory medications, so we don't necessarily need new interventions to do this. We just need to acknowledge that male patients might be more susceptible to severe disease and tailor our treatment plans accordingly."

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.